A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis

Table 4 The number of cases achieving treatment goals for ptosis and ophthalmoplegia at different treatment time points

Time	Ptosis		P	Ophthalmoplegia		P
Time	Study group (22 cases)	Control group (38 cases)	P	Study group (16 cases)	Control group (20 cases)	P
4 weeks	19 (86.3%)	19 (50%)	0.006	12 (75%)	6 (30%)	0.07
12 weeks	19 (86.3%)	23 (60.5%)	0.05	14 (87.5%)	10 (50%)	0.03

Note: In the study group, 3 patients who were treated for 1 month but failed to respond were counted as failing to meet the treatment goals in this table

ISSN: 1471-2415